Synthetic antimicrobial peptides : From choice of the best sequences to action mechanisms
Copyright © 2020 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved..
The emergence of antibiotic-resistant microbes has stimulated research worldwide seeking new biologically active molecules. In this respect, synthetic antimicrobial peptides (SAMPs) have been suggested to overcome this problem. Although there are some online servers that provide putative SAMPs from protein sequences, the choice of the best peptide sequences for further analysis is still difficult. Therefore, the goal of this paper is not to launch a new tool but to provide a friendly workflow to characterize and predict potential SAMPs by employing existing tools. Using this proposed workflow, two peptides (PepGAT and PepKAA) were obtained and extensively characterized. These peptides damaged microbial membranes and cell walls, and induced overproduction of reactive oxygen species (ROS). Both peptides were found to assume random coil secondary structure in aqueous solution, organic solvent, and upon binding to negatively charged lipid systems. Peptides were also able to degrade formed biofilms but not to prevent biofilm formation. PepGAT was not resistant to proteolysis, whereas PepKAA was resistant to pepsin but not to pancreatin. Furthermore, both presented no hemolytic activity against red blood cells, even at a 10-fold higher concentration than the antimicrobial concentration. The pipeline proposed here is an easy way to design new SAMPs for application as alternatives to develop new drugs against human pathogenic microorganisms.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:175 |
---|---|
Enthalten in: |
Biochimie - 175(2020) vom: 15. Aug., Seite 132-145 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Souza, Pedro F N [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Infective Agents |
---|
Anmerkungen: |
Date Completed 05.01.2021 Date Revised 05.01.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.biochi.2020.05.016 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311139469 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311139469 | ||
003 | DE-627 | ||
005 | 20231225141622.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.biochi.2020.05.016 |2 doi | |
028 | 5 | 2 | |a pubmed24n1037.xml |
035 | |a (DE-627)NLM311139469 | ||
035 | |a (NLM)32534825 | ||
035 | |a (PII)S0300-9084(20)30132-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Souza, Pedro F N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synthetic antimicrobial peptides |b From choice of the best sequences to action mechanisms |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.01.2021 | ||
500 | |a Date Revised 05.01.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved. | ||
520 | |a The emergence of antibiotic-resistant microbes has stimulated research worldwide seeking new biologically active molecules. In this respect, synthetic antimicrobial peptides (SAMPs) have been suggested to overcome this problem. Although there are some online servers that provide putative SAMPs from protein sequences, the choice of the best peptide sequences for further analysis is still difficult. Therefore, the goal of this paper is not to launch a new tool but to provide a friendly workflow to characterize and predict potential SAMPs by employing existing tools. Using this proposed workflow, two peptides (PepGAT and PepKAA) were obtained and extensively characterized. These peptides damaged microbial membranes and cell walls, and induced overproduction of reactive oxygen species (ROS). Both peptides were found to assume random coil secondary structure in aqueous solution, organic solvent, and upon binding to negatively charged lipid systems. Peptides were also able to degrade formed biofilms but not to prevent biofilm formation. PepGAT was not resistant to proteolysis, whereas PepKAA was resistant to pepsin but not to pancreatin. Furthermore, both presented no hemolytic activity against red blood cells, even at a 10-fold higher concentration than the antimicrobial concentration. The pipeline proposed here is an easy way to design new SAMPs for application as alternatives to develop new drugs against human pathogenic microorganisms | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Antibiofilm activity | |
650 | 4 | |a Candida | |
650 | 4 | |a Dermatophyte | |
650 | 4 | |a Peptide design | |
650 | 4 | |a SAMP | |
650 | 7 | |a Anti-Infective Agents |2 NLM | |
650 | 7 | |a Pore Forming Cytotoxic Proteins |2 NLM | |
650 | 7 | |a Reactive Oxygen Species |2 NLM | |
700 | 1 | |a Marques, Lidyane S M |e verfasserin |4 aut | |
700 | 1 | |a Oliveira, Jose T A |e verfasserin |4 aut | |
700 | 1 | |a Lima, Patrícia G |e verfasserin |4 aut | |
700 | 1 | |a Dias, Lucas P |e verfasserin |4 aut | |
700 | 1 | |a Neto, Nilton A S |e verfasserin |4 aut | |
700 | 1 | |a Lopes, Francisco E S |e verfasserin |4 aut | |
700 | 1 | |a Sousa, Jeanlex S |e verfasserin |4 aut | |
700 | 1 | |a Silva, Ayrles F B |e verfasserin |4 aut | |
700 | 1 | |a Caneiro, Rômulo F |e verfasserin |4 aut | |
700 | 1 | |a Lopes, Jose L S |e verfasserin |4 aut | |
700 | 1 | |a Ramos, Márcio V |e verfasserin |4 aut | |
700 | 1 | |a Freitas, Cleverson D T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biochimie |d 1971 |g 175(2020) vom: 15. Aug., Seite 132-145 |w (DE-627)NLM000014419 |x 1638-6183 |7 nnns |
773 | 1 | 8 | |g volume:175 |g year:2020 |g day:15 |g month:08 |g pages:132-145 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biochi.2020.05.016 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 175 |j 2020 |b 15 |c 08 |h 132-145 |